K
Kura Oncology, Inc.
KURA · NASDAQ · Healthcare · 964M
Price · close
$11.89
+1.54% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
6.0×
Enterprise value / EBITDAEV/EBITDA
-3.3×
Free cash flow yieldFCF yield
-6.8%
Return on equityROE
-160.0%
Operating margin
-449.9%
Net debt / EBITDAbalance-sheet strength
0.5×
Interest coverage
-200.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.